| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 33, 2034-2038, Copyright © 1987 by American Association for Clinical Chemistry
JE Howey, MC Browning and CG Fraser
Department of Biochemical Medicine, Ninewells Hospital and Medical School, Scotland, U.K.
To investigate the optimum specimen for quantifying low, but abnormal, concentrations of albumin in urine, we assessed the analytical and biological components of variation in first morning, random untimed, and 24-h urine specimens from 11 apparently healthy individuals. The results were expressed in terms of albumin concentration, albumin/creatinine ratio, and albumin excretion rate. Analytical methods generally can meet the analytical goal of CV less than or equal to 18%. For reasons detailed herein, we prefer measurement of the albumin concentration in the first morning specimen. Expressing results as an albumin/creatinine ratio has little advantage. Albumin concentrations in first morning urines from 16 diabetic subjects showed larger intra-individual variation than for nondiabetic subjects but clearly fell into two groups: those with consistently normal albumin concentrations in urine and those with abnormal concentrations in some specimens. The intrinsic biological variation of the latter group means that the ideal 100% nosological specificity cannot be achieved with any cutoff point without inclusion of a large proportion of the former. Qualitative testing with a latex-agglutination technique also demonstrates this problem. Use of data on biological variation allows development of an appropriate clinical strategy to investigate diabetic patients.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  E. C. Witte, H. J. Lambers Heerspink, D. de Zeeuw, S. J.L. Bakker, P. E. de Jong, and R. Gansevoort First Morning Voids Are More Reliable Than Spot Urine Samples to Assess Microalbuminuria J. Am. Soc. Nephrol., February 1, 2009; 20(2): 436 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. McQueen and A. C. Don-Wauchope Requesting and Interpreting Urine Albumin Measurements in the Primary Health Care Setting Clin. Chem., October 1, 2008; 54(10): 1595 - 1597. [Full Text] [PDF]
|
|
|
|
|
|
H. W. Vesper, L. M. Demers, R. Eastell, P. Garnero, M. Kleerekoper, S. P. Robins, A. K. Srivastava, G. R. Warnick, N. B. Watts, and G. L. Myers Assessment and Recommendations on Factors Contributing to Preanalytical Variability of Urinary Pyridinoline and Deoxypyridinoline Clin. Chem., February 1, 2002; 48(2): 220 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.K. Shihabi, R.P. Schwartz, and M.J. Pugia Decreasing the Variability Observed in Urine Analysis Ann. Clin. Lab. Sci., January 1, 2001; 31(1): 99 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Batlle-Gualda, A. C. Martínez, R. A. Guerra, and E. Pascual Urinary albumin excretion in patients with systemic lupus erythematosus without renal disease Ann Rheum Dis, June 1, 1997; 56(6): 386 - 389. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. J. McKenna, C. Arias, C. S. Feldkamp, and F. W. Whitehouse Microalbuminuria in Clinical Practice Arch Intern Med, September 1, 1991; 151(9): 1745 - 1747. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
